Milwaukee shoulder syndrome (MSS) usually occurs in elderly, especially female, patients and is a form of destructive arthropathy, often bilateral1. MSS is associated with the presence of basic calcium phosphate crystals (primarily hydroxyapatite) in the synovial fluid2.
An 82-year-old female presented with bilateral shoulder swelling and numbness of the left arm for 3 years. Medical history was unremarkable. Her shoulders were severely swollen, and her active range of motion was restricted to mild abduction. Radiographs showed the complete absence of the bilateral glenohumeral joints (Figure 1). Ultrasonography and magnetic resonance imaging (MRI) of the shoulders revealed a mass suggestive of hematoma. MRI of the neck was unremarkable. Aspirated synovial fluid was hemorrhagic and the analysis was unremarkable (a few white blood cells and no organism by Gram stain; no crystals by polarized light microscopy). Alizarin red S staining revealed positive-stained materials consistent with hydroxyapatite crystals within the fluid. All cultures and PCR for Mycobacterium tuberculosis were negative, and several biopsies of the synovium revealed no malignancy. After extensive clinical workup to exclude differential diagnoses, the patient was diagnosed with MSS.
Radiograph shows the complete absence of the glenohumeral joint.
Treatment of MSS is supportive, with symptom relief as its goal. Shoulder joint replacement is an effective intervention but has to be performed before the rotator cuffs tear completely. There is a case report of a good response to colchicine and nonsteroidal antiinflammatory drugs3.
In this present case, the patient has been followed up with colchicine and rest, as there was no indication for arthroplasty. Six months later, she continued without any worsening pain.
Acknowledgment
We thank Editage (www.editage.jp) for English language editing.
Footnotes
Informed consent from the proxy of the patient was obtained. We received approval of research ethics committee of Japanese Red Cross Kumamoto Hospital (approval number: No 19-41).